Manzo Pharmaceuticals Inc. (MNZO)

[OPKOHEALTH2022]

Celprogen has made other deals to pump up other penny stocks: The company is MDIN and it was a TOTAL PUMP AND DUMP!

On May 20, 2013 the Company acquired a patent license from Celprogen Inc. for an unlimited license to use their patent for a lactose intolerance cure and the only term is that the company pay a 2% royalty on the net profit generated annually in exchange for 400,000,000 common shares. On February 10, 2014 330,540,099 shares of this agreement were cancelled, however the agreement is still in effect.

Your quote :
"Celprogen is a major company that focus on Stem - Cell Research an it doesn't just team up with some crappy penny stock to make a pump "